Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • France
    • +34 96 390 53 10 Request Information
    • +34 96 390 53 10 Request Information
    FranceFrance
    • France
      • Part of brands: |
        • Nous Vous Guidons
          • Fertilité
          • Prevent inherited diseases
          • Worry-free pregnancy
        • Santé Reproductive
          • Specialists
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • PGT-A
            • PGT-M
            • POC
            • SAT
          • Patients
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • PGT-A
            • PGT-M
            • SAT
            • POC
        • À Propos de Nous
          • Igenomix Recherche
          • À propos d’Igenomix
        • Webinaires
        Genomics Precision Diagnostic > Prenatal > Embryo Developmental Arrest Precision Panel

        Embryo Developmental Arrest Precision Panel

        Embryo Developmental Arrest (EDA) is one of the mechanisms responsible for an increased level of embryo demise during the first week of in vitro development. Around 10-15% embryos permanently arrest in mitosis at the 2-to 4-cell cleavage stage.
        Overview
        Indication
        Clinical Utility
        Genes & Diseases
        Methodology
        References

        Overview

        • Embryo Developmental Arrest (EDA) is one of the mechanisms responsible for an increased level of embryo demise during the first week of in vitro development. Around 10-15% embryos permanently arrest in mitosis at the 2-to 4-cell cleavage stage. It involves the downregulation and/or cessation of cell division and metabolic activity of the components involved in the formation and development of an embryo. Chromosomal abnormalities, abnormal preimplantation development and single gene disorders have been stated as causes of EDA and therefore, a known cause of infertility. The identification of abnormal gene changes previously known to have an effect on embryo development is crucial to improve pregnancy outcomes.  

        • The Igenomix Embryo Developmental Arrest Precision Panel can be used to make a directed and accurate differential diagnosis of inability to carry out a full pregnancy ultimately leading to a better management and achieve a healthy baby at home. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved.  

        Indication

        • The Igenomix Infertility Precision Panel is indicated for those patients with clinical suspicion of infertility presenting with the following manifestations: 
          • Inability to conceive after 1 year of unprotected intercourse  
          • Family history of infertility  
          • Personal or family history of recurrent miscarriages  
          • Previous failed IVF cycles 
          • Other failed assisted reproductive technology (ART) treatments 

        Clinical Utility

        The clinical utility of this panel is: 

        • The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient.  
        • Early initiation of treatment with a multidisciplinary team for an initial consultation, workup and assisted reproductive technologies (ART). 
        • Risk assessment of asymptomatic family members according to the mode of inheritance. 

        Genes & Diseases

        See all genes and diseases

        GENE 

        OMIM DISEASES 

        INHERITANCE* 

        % GENE COVERAGE (20X) 

        HGMD** 

        BTG4 

        Zygotic Cleavage Failure,
        Female Infertility
         

         

        92.22% 

        NA of NA 

        C1QC 

        C1q Deficiency 

        AR 

        100% 

        11 of 11 

        CATSPER1 

        Spermatogenic 
        Failure 

        AR 

        99.97% 

        4 of 4 

        CD46 

        HELLP Syndrome, 
        Hemolytic Uremic
        Syndrome
         

        AD,AR 

        100% 

        83 of 84 

        CNOT6L 

        Embryo
        Developmental
        Arrest
         

        – 

        98.92% 

        NA of NA 

        DMC1 

        Infertility 

        – 

        100% 

        2 of 2 

        DNAH1 

        Primary Ciliary Dyskinesia,
        Spermatogenic Failure
         

        AR 

        100% 

        58 of 58 

        DNAH5 

        Primary Ciliary
        Dyskinesia
        With Or Without
        Situs Inversus
         

        AR 

        100% 

        277 of 278 

        DPY19L2 

        Spermatogenic Failure 

        AR 

        97.65% 

        16 of 20 

        EED 

        Cohen-Gibson Syndrome,
        Weaver Syndrome
         

        AD 

        99.92% 

        10 of 10 

        GALNTL5 

        Primary Infertility Due
        to 
        Asthenozoospermia 

         

        99.95% 

        2 of 2 

        KHDC3L 

        Recurrent Hydatidiform 
        Mole, 
        Recurrent 

        AR 

        100% 

        7 of 7 

        KLHL10 

        Male Infertility With
        Azoospermia Or 
        Oligozoospermia Due
        To Single Gene Mutation,
        Spermatogenic Failure
         

        AD 

        99.98% 

        5 of 5 

        NANOG 

        Teratocarcinoma,
        Germ Cell and Embryonal
        Cancer
         

         

        97.74% 

        NA of NA 

        NANOS1 

        Male Infertility With
        Azoospermia Or 
        Oligozoospermia Due
        To Single Gene Mutation,
        Male Infertility With 
        Teratozoospermia Due
        To Single Gene Mutation,
        Spermatogenic Failure
         

        AD 

        75.55% 

        2 of 3 

        NR5A1 

        46XX Gonadal Dysgenesis,
        46XX 
        Ovotesticular Disorder
        Of Sex Development, 46XX
        Sex Reversal, 46XX Testicular
        Disorder Of Sex Development,
        46XY Complete Gonadal
        Dysgenesis,
        Male Infertility With Azoospermia
        Or 
        Oligozoospermia Due To
        Single Gene Mutation,
        Premature Ovarian Failure,
        Spermatogenic Failure
         

        AD 

        99.97% 

        222 of 224 

        PADI6 

        Preimplantation 
        Embryonic Lethality 

        AR 

        NA 

        NA 

        PICK1 

        Spermatogenic
        Failure, Depression
         

         

        100% 

        1 of 1 

        PLCZ1 

        Spermatogenic 
        Failure 

        AR 

        99.78% 

        8 of 8 

        POU5F1 

        Embryonal Carcinoma,
        Teratoma
         

         

        100% 

        1 of 1 

        SEPTIN12 

        Spermatogenic Failure 

        AD 

        99.84% 

        5 of 5 

        SLC26A8 

        Spermatogenic Failure 

        AD 

        98.81% 

        5 of 5 

        SPATA16 

        Spermatogenic Failure 

        AR 

        99.94% 

        1 of 2 

        SPP1 

        Pediatric Systemic
         Lupus Erythematosus 

         

        99.77% 

        2 of 2 

        STAT3 

        Acute Promyelocytic 
        Leukemia,
        Infantile-Onset
        Autoimmune Disease,
        Hyper-
        IgE Syndrome,
        Permanent Neonatal
        Diabetes Mellitus
         

        AD 

        100% 

        171 of 171 

        STK11 

        Pancreatic Cancer,
        Peutz-Jeghers Syndrome,
        Testicular
         Tumor 

        AD 

        81.99% 

        456 of 470 

        SUN5 

        Male Infertility Due To 
        Acephalic Spermatozoa,
        Spermatogenic Failure
         

        AR 

        100% 

        14 of 14 

        SYCE1 

        Male Infertility With
        Azoospermia Or 
        Oligozoospermia Due
        To Single Gene Mutation,
        Premature Ovarian Failure,
        Spermatogenic Failure
         

        AR 

        100% 

        2 of 3 

        TAF4B 

        Male Infertility With
        Azoospermia Or 
        Oligozoospermia 
        Due To Single Gene
        Mutation, Spermatogenic
        Failure
         

        AR 

        97.92% 

        0 of 1 

        TERT 

        Aplastic Anemia, 
        Dyskeratosis Congenita, 
        Familial Melanoma,
         
        Hoyeraal-Hreidarsson 
        Syndrome,
         
        Idiopathic Aplastic 
        Anemia, 
        Idiopathic 
        Pulmonary Fibrosis, 
        Acute Myeloid Leukemia, 
        Cutaneous Malignant Melanoma, 
        Meningioma, Pulmonary 
        Fibrosis And/
        Or Bone Marrow Failure, 
        Telomere-related, Pulmonary Fibrosis 

        AD,AR 

        99.09% 

        194 of 197 

        TEX11 

        Male Infertility With
        Azoospermia Or 
        Oligozoospermia
         Due To Single Gene
        Mutation, X-linked
        Spermatogenic Failure
         

        X,XR,G 

        96.52% 

        NA of NA 

        TEX15 

        Male Infertility With
        Azoospermia Or
         
        Oligozoospermia
         Due To Single Gene
        Mutation, Spermatogenic
        Failure
         

        AR 

        99.16% 

        6 of 7 

        TLE6 

        Preimplantation 
        Embryonic Lethality 

        AR 

        100% 

        2 of 2 

        TUBB8 

        Oocyte Maturation 
        Defect 

        AD,AR 

        99.81% 

        47 of 47 

        VSIG4 

        T-cell/Histiocyte
        Rich Large B Cell
        Lymphoma, Complement Component 3
        Deficiency, 
        Hemolytic Uremic
        Syndrome
         

        – 

        99.80% 

        NA of NA 

        ZFP42 

        Spermatocytoma,
        Germ Cell and
        Embryonal Cancer
         

        – 

        99.98% 

        NA of NA 

        ZP1 

        Oocyte Maturation 
        Defect 

        AR 

        100% 

        17 of 17 

        ZPBP 

        Spermatogenic Failure 

         

        99.98% 

        4 of 4 

        * Inheritance: AD: Autosomal Dominant; AR: Autosomal Recessive; X: X linked; XLR: X linked Recessive; Mi: Mitochondrial; Mu: Multifactorial 

        ** HGMD: Number of clinically relevant mutations according to HGMD

        Methodology

        References

        See scientific referrals

        Murphy, B. (2020). Under Arrest: The Embryo in Diapause. Developmental Cell, 52(2), 139-140. doi: 10.1016/j.devcel.2020.01.002 

        Levy, R. R., Cordonier, H., Czyba, J. C., & Guerin, J. F. (2001). Apoptosis in preimplantation mammalian embryo and genetics. Italian journal of anatomy and embryology = Archivio italiano di anatomia ed embriologia, 106(2 Suppl 2), 101–108. 

        Mohebi, M., & Ghafouri-Fard, S. (2019). Embryo developmental arrest: Review of genetic factors and pathways. Gene Reports, 17, 100479. doi: 10.1016/j.genrep.2019.100479 

        Zhang, X., Stojkovic, P., Przyborski, S., Cooke, M., Armstrong, L., Lako, M., & Stojkovic, M. (2006). Derivation of Human Embryonic Stem Cells from Developing and Arrested Embryos. Stem Cells, 24(12), 2669-2676. doi: 10.1634/stemcells.2006-0377 

        Sha, Q. Q., Zheng, W., Wu, Y. W., Li, S., Guo, L., Zhang, S., Lin, G., Ou, X. H., & Fan, H. Y. (2020). Dynamics and clinical relevance of maternal mRNA clearance during the oocyte-to-embryo transition in humans. Nature communications, 11(1), 4917. https://doi.org/10.1038/s41467-020-18680-6 

        Zhang, Y., Feng, Y., & Ma, F. (2020). Yi chuan = Hereditas, 42(10), 1004–1016. https://doi.org/10.16288/j.yczz.20-144 

        Feng, R., Yan, Z., Li, B., Yu, M., Sang, Q., Tian, G., Xu, Y., Chen, B., Qu, R., Sun, Z., Sun, X., Jin, L., He, L., Kuang, Y., Cowan, N. J., & Wang, L. (2016). Mutations in TUBB8 cause a multiplicity of phenotypes in human oocytes and early embryos. Journal of medical genetics, 53(10), 662–671. https://doi.org/10.1136/jmedgenet-2016-103891 

        Xu, Y., Shi, Y., Fu, J., Yu, M., Feng, R., & Sang, Q. et al. (2016). Mutations in PADI6 Cause Female Infertility Characterized by Early Embryonic Arrest. The American Journal Of Human Genetics, 99(3), 744-752. doi: 10.1016/j.ajhg.2016.06.024 

        BROCHURE

        Download

        Request Information


        • reCAPTCHA demo: Simple page

        Fertilité

        Fertilité
        Éviter les maladies génétiques

        Test prénatal non-invasif

        Pour voir le certificat d'accréditation, l'annexe technique associée et la liste des tests accrédités, cliquez sur ce lien.

        Nos services

        Nos services
        Patients
        D'envoyer les échantillons
        Manuel d'utilisateur

        À propos d’Igenomix

        À propos d’Igenomix
        Igenomix dans le monde
        Quality
        Work with us

        SUIVRE IGENOMIX

          + 96 390 53 10
        Écrivez-nous
        • Argentina
        • Brazil
        • Canada
        • Chile
        • Colombia
        • Europe
        • France
        • Germany
        • India
        • Italy
        • Japan
        • Korea
        • Mexico
        • Perú
        • Russia
        • Spain
        • Taiwan
        • The Middle East
        • Turkey
        • United Kingdom
        • United States
        • Vietnam
        France

        [2021] © Igenomix Politique de confidentialité Politique de qualité Note juridique Politique de cookiesActualités et presse 

        Demander des informations


        • reCAPTCHA demo: Simple page

        • Nous Vous Guidons
          • Fertilité
          • Prevent inherited diseases
          • Worry-free pregnancy
        • Santé Reproductive
          • Specialists
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • PGT-A
            • PGT-M
            • POC
            • SAT
          • Patients
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • PGT-A
            • PGT-M
            • SAT
            • POC
        • À Propos de Nous
          • Igenomix Recherche
          • À propos d’Igenomix
        • Webinaires
        • France
        • +34 96 390 53 10 Request Information

        We are using cookies to give you the best experience on our website.

        You can find out more about which cookies we are using or switch them off in settings.

        France
        Powered by  GDPR Cookie Compliance
        Privacy Overview

        This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

        Strictly Necessary Cookies

        Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

        If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.